Chief of Clinical Effectiveness and Innovation at Harvard Vanguard Medical Associates in Massachusetts
Zeev Neuwirth on KCRW
More from KCRW
CA’s Prop 1 narrowly passes to reform mental health spending
PoliticsWith the narrow approval of Governor Gavin Newsom’s $6.4 billion mental health bond, Prop 1, the work begins to build thousands of treatment beds.
Prioritizing happiness in state laws is focus of new committee
PoliticsA committee wants to invest in the happiness of Californias with data-proven ideas. But a multi-billion dollar state budget deficit looms over their efforts.
Plans for Rafah offensive could divide Netanyahu and US Democrats
PoliticsHow will a continued offensive in Gaza affect Democratic support for Israel? Can SCOTUS clear up the lines between censorship and free speech?
How OC changes without Katie Porter in Senate
Orange CountyKatie Porter’s influence turned Orange County competitive, but after her Senate race loss, Democrats now face the challenge of keeping that same momentum going.
Do legislative failures this week signal trouble in the GOP?
PoliticsWill failing to pass a border security bill backfire on Republicans? Can Joe Biden reconnect with Arab and Muslim communities? Plus, a moving Grammys duet provides a lesson.
NPR Special Coverage - State of the Union
PoliticsOn Thursday, March 7, President Biden will deliver the State of the Union address to a Joint Session of Congress. Tune into KCRW to follow along NPR's live coverage at 6 p.m. PST.
CA won’t have a woman senator for first time in 30 years
PoliticsAdam Schiff or Steve Garvey will become the state’s next senator. Abortion access and pay equity will fall more heavily under the purview of men in the Senate.
NPR Special Coverage: New Hampshire Primary
PoliticsNew Hampshire holds its "first in the nation" primary election this coming Tuesday, January 23.
Israel does not speak for Jews like us
InternationalOn this episode of the Scheer Intelligence podcast, Heyday Books publisher and former LA Times book editor Steve Wasserman and host Robert Scheer commit themselves to this conversation…